Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen

摘要

BackgroundSynuclein gamma (SNCG), initially identified as a breast cancer specific gene, is aberrantly expressed in many different malignant tumors but rarely expressed in matched nonneoplastic adjacent tissues. In this study, we investigated the prognostic potential of SNCG in colon cancer particularly in the patients with normal carcinoembryonic antigen (CEA) levels.